Skip to Content

CP 419 (Aspirin, Caffeine, and Dihydrocodeine Bitartrate 356.4 mg / 30 mg / 16 mg)

Pill with imprint CP 419 is Blue & Gray, Capsule-shape and has been identified as Aspirin, Caffeine, and Dihydrocodeine Bitartrate 356.4 mg / 30 mg / 16 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Aspirin/caffeine/dihydrocodeine is used in the treatment of pain and belongs to the drug class narcotic analgesic combinations. FDA has not classified the drug for risk during pregnancy. Aspirin/caffeine/dihydrocodeine 356.4 mg / 30 mg / 16 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for CP 419

Aspirin, Caffeine, and Dihydrocodeine Bitartrate

Imprint:
CP 419
Strength:
356.4 mg / 30 mg / 16 mg
Color:
Blue & Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
N - Not classified
CSA Schedule:
3 - Moderate abuse potential
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC):
57664-0419

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide